The Significance of Modern Technologies in the Treatment of Uterine Fibroids as a Threat to Women’s Reproductive Health

Authors

  • Ro’zmetova Roziyajon Yoqubboy qizi 4th-year student, Faculty of General Medicine, Termez Branch of Tashkent State Medical University
  • Rustamova Sevinch Shuxrat qizi 3rd-year student, Faculty of General Medicine, Kimyo International University in Tashkent (Med-01U)
  • Akramova Nigina Bahrom qizi 1st-year Clinical Resident, Samarkand State Medical University
  • Turgʻunpoʻlatova Mahliyo Odiljon qizi Student, Faculty of General Medicine, Andijan State Medical Institute
  • O‘ralova Aziza Faridovna 1st-year student, Faculty of General Medicine, TDTUTF

Keywords:

Uterine fibroids, leiomyoma, reproductive health, minimally invasive surgery, uterine artery embolization, robot-assisted surgery

Abstract

Uterine fibroids (leiomyomas) are among the most common benign gynecological tumors in women, affecting up to 20–50% of women of reproductive age. This pathology is associated with menstrual disorders, chronic posthemorrhagic anemia, pelvic pain syndrome, infertility, and various pregnancy complications. In recent years, rapid advances in high-technology and minimally invasive approaches in gynecology have enabled uterus-preserving treatment strategies, reduced surgical trauma, and maximized protection of women’s reproductive health. This article analyzes the clinical effectiveness and scientific rationale of modern technologies used in the diagnosis and treatment of uterine fibroids.

References

1. Khudoyberdiyeva NN. Pathophysiology and treatment strategies of uterine fibroids. Tashkent Medical Journal. 2020;1(2):45–53.

2. Islomov BSh. Clinical manifestations of uterine fibroids in women of reproductive age. Medical Information of Uzbekistan. 2022;6(3):12–19.

3. Jorayeva Ish, Rozmatova RY. The impact of fibroids in IVF patients and treatment approaches. Gynecology and Obstetrics. 2020;4(1):22–30.

4. Karimova DR. Laparoscopic myomectomy practice: clinical observations. Tashkent Clinical Journal. 2021;2(4):15–23.

5. Tokhtayeva LX. National experience with MR-guided focused ultrasound technology. Radiology and Diagnostics. 2023;5(2):9–17.

6. Abdullayeva MA. The significance of 3D ultrasound diagnostics. Uzbekistan Medical Journal. 2022;3(5):34–41.

7. Rahimov UK. Hysteroscopy and minimally invasive approaches. Gynecological Examinations. 2020;1(3):8–15.

8. Saidov FS. Uterine artery embolization: CIS experience. Interventional Radiology. 2022;4(1):25–32.

9. Karimov AA. Genetic mechanisms and MED12 mutations. Biomedical Research. 2022;6(2):12–20.

10. Rustamova SSh. Minimally invasive surgery and reproductive outcomes. Tashkent Clinical Journal. 2021;2(2):18–27.

11. Stewart EA. Uterine fibroids. The Lancet. 2015;386:293–298.

12. Bulun SE. Uterine fibroids. New England Journal of Medicine. 2013;369:1344–1355.

13. Donnez J, Dolmans MM. Uterine fibroids and fertility. Human Reproduction Update. 2016;22(6):665–686.

14. Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Obstetrics & Gynecology. 2018;131:109–120.

15. Vilos GA, et al. Uterine artery embolization for fibroids. Journal of Obstetrics and Gynaecology Canada. 2019;41(7):985–999.

Downloads

Published

2026-01-27

How to Cite

Yoqubboy qizi, R. R., Shuxrat qizi, R. S., Bahrom qizi, A. N., Odiljon qizi, T. M., & Faridovna, O. A. (2026). The Significance of Modern Technologies in the Treatment of Uterine Fibroids as a Threat to Women’s Reproductive Health. International Journal of Integrative and Modern Medicine, 4(1), 159–161. Retrieved from https://medicaljournals.eu/index.php/IJIMM/article/view/2613

Similar Articles

<< < 27 28 29 30 31 32 33 34 35 36 > >> 

You may also start an advanced similarity search for this article.